Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.687
+0.027 (4.06%)
At close: Jan 21, 2025, 4:00 PM
0.700
+0.013 (1.91%)
After-hours: Jan 21, 2025, 6:32 PM EST
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 325 employees as of December 31, 2023. The number of employees decreased by 60 or -15.58% compared to the previous year.
Employees
325
Change (1Y)
-60
Growth (1Y)
-15.58%
Revenue / Employee
$456,745
Profits / Employee
-$269,166
Market Cap
86.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
KPTI News
- 8 days ago - Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives - PRNewsWire
- 19 days ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 19 days ago - Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer - PRNewsWire
- 6 weeks ago - Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications - PRNewsWire
- 7 weeks ago - Karyopharm Therapeutics Provides Endometrial Cancer Program Update - PRNewsWire
- 2 months ago - Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 2 months ago - Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer - PRNewsWire
- 2 months ago - Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition - PRNewsWire